Sitemap - 2018 - Mendelspod

Amy Harmon of the NYT on Race & Genetics, Women in Science

CRISPR or Not, You Can't Genetically Enhance Humans, Says Sci-Fi Author Kim Stanley Robinson

The New World of Infectious Disease Diagnosis: Out in the Field with David Hong of Karius

California Life Science Industry Steps to New Heights - the 2019 Edition with Sara Radcliffe

Nathan and Laura on CRISPRed Babies and Other November 2018 Stories

Ellen Matloff on a New Digital Genetic Counseling Product for DTC Customers

Connecting the Dots for a Community of Rare Disease Patients: Terri Klein, MPS Society

Keith Robison and Shawn Baker on Illumina Buyout of PacBio

October 2018 Review with Nathan and Laura: ASHG Does Race, Parents Do Gene Therapy, Unsung Demons

A Point-of-Care CBC Test Based on a Few Drops of Blood—Is This the Real Thing? with Danny Levner, Sight Diagnostics

It’s a Gold Rush in Single Cell Genomics, Says Joachim Schultze, U of Bonn

A Market Solution for Biospecimen Quality Standards with Matt McLoughlin, Scientist.com

September 2018 with Nathan and Laura: Studying the Same Genes and the Matt Fender Story

Single Cell Sequencing Tailor Made for Nephrology, Says Vivek Bhalla, Stanford

It’s the Social Factors, Stupid! Lisa Suennen on Healthcare, Her Career, Digital Health Investing, and . . . Just Being Herself

Concerned About DTC Test Quality? Ask Two Questions, Says Daryl Pritchard, PMC

August 2018 Review with Nathan and Laura: The polygenic month

An International Perspective on How to Improve Biobanking with Kirstin Goldring

A Seqster Preview with Founder Ardy Arianpour

Detective Stories from the Genomic War Room with Ramesh Hariharan

Should Biobanking Come Under CLIA? Shannon McCall, Duke

Pharma Stepping Up, Footing the Bill for Genetic Testing & Counseling: Jordanna Mora, Alnylam

Are We Asking Too Much of Genomics in Cancer Research? Tony Letai, Dana Farber

I Won’t Rest Until We Have Quality Standards in Place for Biospecimens: Carolyn Compton, ASU

May 2018 with Nathan and Laura: The Free Exome, California Database, and Mosaicism

Has Diagnostic Testing Plateaued? Alka Chaubey, Greenwood Genetic Center

A New Way for DTC? Nathan Pearson, Root Deep Insight

Genetic Testing in the Age of Trump: Hank Greely, Stanford

Genetic Testing is Dead, Long Live Genetic Testing: Sean George of Invitae

April 2018 with Nathan and Laura: Golden State Killer and the Cancer Prediction Space

Liquid Biopsy for Infectious Disease with Mickey Kertesz, Karius

Nanopore Sequencing and the Future of Cancer Research with Chia-Lin Wei, JAX

A New Method for Long Reads: Hanlee Ji of Stanford on Cancer Genomics Tech 2018

March 2018 in Genomics with Nathan & Laura: DTC BRCA and Revisiting All of Us

With More Tools in the Box, Lon Cardon Says We’re in a New Age of Drug Development

Personalized Medicine in the Trump Era with Edward Abrahams

Eric Schadt and Sema4 Try the Consumer Model with Newborn Screening Panel

February 2018 in Genomics with Nathan & Laura: 23andMe Goes for the Gold, Trump Year One

State of Sequencing 2018 with Keith Robison, Omics! Omics! Blogger

Direct RNA-Seq Project Shows Nanopore Sequencing Can Reveal New Insights into Basic Biology: Winston Timp, JHU

January 2018 Review Show with Nathan and Laura: CRISPR vs The Immune System, Biotech Math, and MinION's Big Test

Going Beyond the Liver with RNAi: Chris Anzalone of Arrowhead Pharma

Vice Chancellor Keith Yamamoto on UCSF’s Role in Medicine Today

The Global Business of Reproductive Genetic Testing with Gary Harton, Igenomix

The State of Genomics 2018 with Nathan, Laura, and Misha